AskBio's Acquisition

AskBio was acquired by Baxter International on April 02, 2014.

Asklepios BioPharmaceutical (AskBio), fka Chatham Therapeutics, is a clinical development-stage biotechnology company engaged in the development of novel, gene therapy-mediated treatments for hemophil…

Articles about AskBio's Acquisition: